Page 613 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 26 Tumors of the Endocrine System 591

224. Broome MR, Peterson ME, Walker JR: Clinical features and treat- 247. Turrel JM, Feldman EC, Nelson RW, et al.: Thyroid carcinoma
ment outcomes of 41 dogs with sublingual ectopic thyroid neopla- causing hyperthyroidism in cats: 14 cases (1981-1986), J Am Vet
sia, J Vet Intern Med 28:1560–1568, 2014. Med Assoc 193:359–364, 1988.
VetBooks.ir 225. Milovancev M, Wilson DM, Monnet E, et al.: Partial resection 248. Cook SM, Daniel GB, Walker MA, et al.: Radiographic and scin-
of the hyoid apparatus during surgical treatment of ectopic thy-
tigraphic evidence of focal pulmonary neoplasia in three cats with
roid carcinomas in dogs: 5 cases (2011-2013), J Am Vet Med Assoc
244:1319–1324, 2014. hyperthyroidism: diagnostic and therapeutic considerations, J Vet
Intern Med 7:303–308, 1993.
226. Kang MH, Kim DY, Park HM: Ectopic thyroid carcinoma infil- 249. Hibbert A, Gruffydd-Jones T, Barrett EL, et al.: Feline thyroid
trating the right atrium of the heart in a dog, Can Vet J 53:177– carcinoma: diagnosis and response to high-dose radioactive iodine
181, 2012. treatment, J Feline Med Surg 11:116–124, 2009.
227. Lantz GC, Salisbury SK: Surgical excision of ectopic thyroid carci- 250. Guptill L, Scott-Moncrieff CR, Janovitz EB, et al.: Response to
noma involving the base of the tongue in dogs: three cases (1980- high-dose radioactive iodine administration in cats with thyroid
1987), J Am Vet Med Assoc 195:1606–1608, 1989. carcinoma that had previously undergone surgery, J Am Vet Med
228. Liptak JM, Kamstock DA, Dernell WS, et al.: Cranial mediastinal Assoc 207:1055–1058, 1995.
carcinomas in nine dogs, Vet Comp Oncol 6:19–30, 2008. 251. Miller ML, Peterson ME, Randolph JF, et al.: Thyroid Cysts in
229. Brearley MJ, Hayes AM, Murphy S: Hypofractionated radiation Cats: A Retrospective Study of 40 Cases, J Vet Intern Med 31:723–
therapy for invasive thyroid carcinoma in dogs: a retrospective 729, 2017.
analysis of survival, J Small Anim Pract 40:206–210, 1999. 252. Peterson M: Hyperthyroidism in cats: what’s causing this epidemic
230. Pack L, Roberts RE, Dawson SD, et al.: Definitive radiation ther- of thyroid disease and can we prevent it? J Feline Med Surg 14:804–
apy for infiltrative thyroid carcinoma in dogs, Vet Radiol Ultrasound 818, 2012.
42:471–474, 2001. 253. Carney HC, Ward CR, Bailey SJ, et al.: 2016 AAFP guidelines
231. Tsimbas K, Turek M, Christensen N, et al.: Short survival time for the management of feline hyperthyroidism, J Feline Med Surg
following palliative-intent hypofractionated radiotherapy for non- 18:400–416, 2016.
resectable canine thyroid carcinoma: a retrospective analysis of 254. Kohler I, Ballhausen BD, Stockhaus C, et al.: Prevalence of and
20 dogs, Vet Radiol Ultrasound, 2018. https://doi.org/10.1111/ risk factors for feline hyperthyroidism among a clinic population
vru.12680. in Southern Germany, Tierarztl Prax Ausg K Kleintiere Heimtiere
232. Amores-Fuster I, Cripps P, Blackwood L: Post-radiotherapy hypo- 44:149–157, 2016.
thyroidism in dogs treated for thyroid carcinomas, Vet Comp Oncol 255. Wakeling J, Everard A, Brodbelt D, et al.: Risk factors for feline
15:247–251, 2017. hyperthyroidism in the UK, J Small Anim Pract 50:406–414, 2009.
233. Worth AJ, Zuber RM, Hocking M: Radioiodide (131I) therapy for 256. Edinboro CH, Scott-Moncrieff JC, Glickman LT: Feline hyperthy-
the treatment of canine thyroid carcinoma, Aust Vet J 83:208–214, roidism: potential relationship with iodine supplement requirements
2005. of commercial cat foods, J Feline Med Surg 12:672–679, 2010.
234. Turrel JM, McEntee MC, Burke BP, et al.: Sodium iodide i 131 257. van Hoek I, Hesta M, Biourge V: A critical review of food-associ-
treatment of dogs with nonresectable thyroid tumors: 39 cases ated factors proposed in the etiology of feline hyperthyroidism, J
(1990-2003), J Am Vet Med Assoc 229:542–548, 2006. Feline Med Surg 17:837–847, 2015.
235. Castillo V, Pessina P, Hall P, et al.: Post-surgical treatment of thy- 258. Walter KM, Lin YP, Kass PH, et al.: Association of polybrominated
roid carcinoma in dogs with retinoic acid 9 cis improves patient diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs)
outcome, Open Vet J 6:6–14, 2016. with hyperthyroidism in domestic felines, sentinels for thyroid
236. Scott-Moncrieff JCR: Canine thyroid tumors and hyperthyroid- hormone disruption, BMC Vet Res 13:120, 2017.
ism. In Feldman EC, Nelson RW, Reusch CE, et al.: Canine and 259. Kass PH, Peterson ME, Levy J, et al.: Evaluation of environmen-
feline endocrinology, ed 4, St. Louis, 2015, Elsevier, pp 196–212. tal, nutritional, and host factors in cats with hyperthyroidism, J Vet
237. Ward CW: Canine hyperthyroidism. In Ettinger SJ, Feldman EC, Intern Med 13:323–329, 1999.
Cote E, editors: Textbook of veterinary internal medicine, ed 8, St. 260. Martin KM, Rossing MA, Ryland LM, et al.: Evaluation of dietary
Louis, 2017, Elsevier, pp 1757–1761. and environmental risk factors for hyperthyroidism in cats, J Am
238. Looney A, Wakshlag J: Dietary management of hyperthyroidism in Vet Med Assoc 217:853–856, 2000.
a dog, J Am Anim Hosp Assoc 53:111–118, 2017. 261. Edinboro CH, Scott-Moncrieff JC, Janovitz E, et al.: Epidemio-
239. Scott-Moncrieff JCR: Feline hyperthyroidism. In Feldman EC, logic study of relationships between consumption of commercial
Nelson RW, Reusch CE, et al.: Canine and feline endocrinology, ed canned food and risk of hyperthyroidism in cats, J Am Vet Med
4, St. Louis, 2015, Elsevier, pp 136–195. Assoc 224:879–886, 2004.
240. Graves TK: Feline hyperthyroidism. In Ettinger SJ, Feldman EC, 262. McLean JL, Lobetti RG, Schoeman JP: Worldwide prevalence and
Cote E, editors: Textbook of veterinary internal medicine, ed 8, St. risk factors for feline hyperthyroidism: a review, J S Afr Vet Assoc
Louis, 2017, Elsevier, pp 1747–1757. 85:1097, 2014.
241. Peterson ME: Animal models of disease: feline hyperthyroidism: an 263. McLean JL, Lobetti RG, Mooney CT, et al.: Prevalence of and
animal model for toxic nodular goiter, J Endocrinol 223:T97–114, risk factors for feline hyperthyroidism in South Africa, J Feline Med
2014. Surg 19:1103–1109, 2017.
242. Naan EC, Kirpensteijn J, Kooistra HS, et al.: Results of thyroid- 264. Hammer KB, Holt DE, Ward CR: Altered expression of G proteins
ectomy in 101 cats with hyperthyroidism, Vet Surg 35:287–293, in thyroid gland adenomas obtained from hyperthyroid cats, Am J
2006. Vet Res 61:874–879, 2000.
243. Peterson ME, Kintzer PP, Cavanagh PG, et al.: Feline hyperthy- 265. Ward CR, Achenbach SE, Peterson ME, et al.: Expression of inhib-
roidism: pretreatment clinical and laboratory evaluation of 131 itory G proteins in adenomatous thyroid glands obtained from
cases, J Am Vet Med Assoc 183:103–110, 1983. hyperthyroid cats, Am J Vet Res 66:1478–1482, 2005.
244. Harvey AM, Hibbert A, Barrett EL, et al.: Scintigraphic findings in 266. Peeters ME, Timmermans-Sprang EP, Mol JA: Feline thyroid ade-
120 hyperthyroid cats, J Feline Med Surg 11:96–106, 2009. nomas are in part associated with mutations in the G(s alpha) gene
245. Peterson ME, Broome MR: Thyroid scintigraphy findings in 2096 and not with polymorphisms found in the thyrotropin receptor,
cats with hyperthyroidism, Vet Radiol Ultrasound 56:84–95, 2015. Thyroid 12:571–575, 2002.
246. Peterson ME, Broome MR, Rishniw M: Prevalence and degree of 267. Ward CR, Windham WR, Dise D: Evaluation of activation of G
thyroid pathology in hyperthyroid cats increases with disease dura- proteins in response to thyroid stimulating hormone in thyroid
tion: a cross-sectional analysis of 2096 cats referred for radioiodine gland cells from euthyroid and hyperthyroid cats, Am J Vet Res
therapy, J Feline Med Surg 18:92–103, 2016. 71:643–648, 2010.